Promising New Treatment For Alzheimer’s Suggested Based On Hebrew University Research0
Promising New Treatment For Alzheimer’s Suggested Based On Hebrew University Research
Research carried out at the Hebrew University of Jerusalem has resulted in a promising approach to help treat Alzheimer’s disease in a significant proportion of the population that suffers from a particularly rapid development of this disease.
New Diagnostic Tool Predicts Risk Of Alzheimer’s
Huliq.com Jul 30 2009 10:19PM GMT
Media Advisory: Lack Of Rules For Genetic Testing Akin To Wild, Wild West, According To Stanford Podcast
With just $399 and a bit of saliva in a cup, consumers can learn about their genetic risk for diseases from breast cancer to Alzheimer’s. Now, thanks to social networking sites set up by personal genomics companies, they can also share that information with family, friends and even strangers on the Internet. Bonding over similar genetic background sounds relatively harmless.
Positive Results For First Disease-Modifying Compound Targeting Protein Misfolding
Discoveries by Scripps Research Institute scientists have led to a promising new drug candidate - the first in its class - for patients with a genetic protein-misfolding disease. In results announced by the biopharmaceutical firm FoldRx Pharmaceuticals, Inc., the new drug tafamidis significantly halts disease progression for patients with a disease called Transthyretin (TTR) amyloid polyneuropathy (ATTR-PN).
Social Security Administration Considers Adding Alzheimer’s To Its Compassionate Allowances List
Today there are an estimated 5.3 million Americans with Alzheimer’s disease. Although the majority of Alzheimer cases are individuals age 65 and older, there is still a significant number of individuals under age 65 impacted by this fatal disease that today has no cure. For people under age 65 with Alzheimer’s disease or a related dementia, their cognitive impairment can quickly reach a point where they can no longer maintain gainful employment.
Office Of The National Alzheimer’s Project Act Will Produce A National Strategic Plan For Alzheimer’s Research, Care, And Related Supportive Services
U.S. Senators Mel Martinez (R-FL) and Evan Bayh (D-IN) introduced a measure to create a collaborated system for researching, treating and eliminating Alzheimer’s disease. The proposal will create an Office of the National Alzheimer’s Project within the White House, and will coordinate all research, clinical care and service toward the prevention, care, and cure of Alzheimer’s.
Alzheimer’s Comment On Research That Genes In Early Onset Are Associated With Memory, Published In Nature, 28 July 2009
Memory is a fundamental function of nerve cells in the brain, and loss of memory is a key symptom in many people with Alzheimer’s disease. In order for memory to function correctly, nerve cells must be able to communicate effectively with each other. Many important proteins in the brain ensure that this communication is maintained between healthy nerve cells by monitoring the junctions, or synapses, between cells.
UK To Play Lead Role In European Fight Against Dementia
The UK will play a leading role in coordinated European action to tackle dementia from. A new initiative launched by the European Commission has adopted proposals to tackle Alzheimer’s disease, dementias and other neurodegenerative conditions. The UK is one of ten countries that will lead research aimed at tackling shared health and social care problems.